NO2999707T3 - - Google Patents
Info
- Publication number
- NO2999707T3 NO2999707T3 NO14725726A NO14725726A NO2999707T3 NO 2999707 T3 NO2999707 T3 NO 2999707T3 NO 14725726 A NO14725726 A NO 14725726A NO 14725726 A NO14725726 A NO 14725726A NO 2999707 T3 NO2999707 T3 NO 2999707T3
- Authority
- NO
- Norway
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13169009 | 2013-05-23 | ||
| EP14725726.5A EP2999707B1 (en) | 2013-05-23 | 2014-05-23 | Tylosin derivatives and method for preparation thereof |
| PCT/EP2014/060665 WO2014187957A1 (en) | 2013-05-23 | 2014-05-23 | Tylosin derivatives and method for preparation thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO2999707T3 true NO2999707T3 (hu) | 2018-08-25 |
Family
ID=48463869
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO14725726A NO2999707T3 (hu) | 2013-05-23 | 2014-05-23 |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US9771389B2 (hu) |
| EP (1) | EP2999707B1 (hu) |
| JP (1) | JP6494600B2 (hu) |
| KR (1) | KR102307218B1 (hu) |
| CN (1) | CN105408340B (hu) |
| AU (1) | AU2014270353B2 (hu) |
| BR (1) | BR112015029260A2 (hu) |
| CA (1) | CA2913098C (hu) |
| CL (1) | CL2015003433A1 (hu) |
| DK (1) | DK2999707T3 (hu) |
| ES (1) | ES2669615T3 (hu) |
| HK (1) | HK1216753A1 (hu) |
| HR (1) | HRP20180877T1 (hu) |
| HU (1) | HUE037868T2 (hu) |
| IL (1) | IL242543B (hu) |
| MX (1) | MX361808B (hu) |
| MY (1) | MY184630A (hu) |
| NO (1) | NO2999707T3 (hu) |
| PE (1) | PE20160207A1 (hu) |
| PL (1) | PL2999707T3 (hu) |
| PT (1) | PT2999707T (hu) |
| RU (1) | RU2714482C2 (hu) |
| SI (1) | SI2999707T1 (hu) |
| TR (1) | TR201809189T4 (hu) |
| UA (1) | UA117751C2 (hu) |
| WO (1) | WO2014187957A1 (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20160303242A1 (en) | 2013-12-09 | 2016-10-20 | Durect Corporation | Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same |
| CN110590885A (zh) * | 2019-09-30 | 2019-12-20 | 郑州大学 | 20-取代-5-o-碳霉胺糖基-泰乐内酯衍生物 |
| CN112898361A (zh) * | 2021-02-01 | 2021-06-04 | 郑州大学 | 5-o-碳霉胺糖基泰乐内酯衍生物及其制备方法及应用 |
| WO2023230702A1 (en) * | 2022-06-03 | 2023-12-07 | University Of Manitoba | Novel antimicrobial compounds isolated using a machine learning model trained on a high-throughput antibacterial screen |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4443436A (en) * | 1982-09-13 | 1984-04-17 | Eli Lilly And Company | C-20-Modified macrolide derivatives of the macrolide antibiotics tylosin, desmycosin, macrocin, and lactenocin |
| AU561147B2 (en) * | 1982-09-13 | 1987-04-30 | Eli Lilly And Company | 20-amino macrolide antibiotics |
| US4468511A (en) * | 1983-02-28 | 1984-08-28 | Eli Lilly And Company | C-20- And C-23-Modified macrolide derivatives |
| IL71032A0 (en) | 1983-02-28 | 1984-05-31 | Lilly Co Eli | C-20 and c-23-modified macrolide derivatives |
| ZA841277B (en) * | 1983-02-28 | 1985-09-25 | Lilly Co Eli | C-20-and c-23-modified macrolide derivatives |
| JPS59186996A (ja) * | 1983-04-05 | 1984-10-23 | Microbial Chem Res Found | ２０−デオキシ−２０−置換アミノ−マイカミノシルレロノライド |
| US4921947A (en) * | 1986-03-31 | 1990-05-01 | Eli Lilly And Company | Process for preparing macrolide derivatives |
| EP0262903A3 (en) * | 1986-09-29 | 1988-11-02 | Eli Lilly And Company | New acyl derivatives of 20-modified tylosin and desmycosin compounds |
| TW226373B (hu) * | 1992-07-15 | 1994-07-11 | Pfizer | |
| NZ250465A (en) | 1992-12-21 | 1995-10-26 | Lilly Co Eli | Bactericidal composition; contains macrolide antibiotic, use for treating aquatic species |
| AU3121095A (en) | 1994-09-22 | 1996-04-09 | Pfizer Inc. | Antibiotic macrolides |
| CA2391834C (en) * | 1999-08-30 | 2008-08-05 | Toshiaki Miyake | Macrolide antibiotics and treatment of pasteurellosis |
| US6506885B1 (en) * | 2001-09-27 | 2003-01-14 | The United States Of America As Represented By The Secretary Of Agriculture | Monoclonal antibodies to the drug tilmicosin and a method for detecting the same |
| US6576615B2 (en) | 2001-11-08 | 2003-06-10 | Enanta Pharmaceuticals, Inc. | 4′-O-substituted tylosin analogs |
| US6664240B2 (en) | 2001-11-15 | 2003-12-16 | Enanta Pharmaceuticals, Inc. | Tylosin derivatives having antibacterial activity |
| US6710034B2 (en) | 2002-04-19 | 2004-03-23 | Enanta Pharmaceuticals, Inc. | 5-O-mycaminosyltylonide derivatives |
| US6753415B2 (en) | 2002-04-19 | 2004-06-22 | Enanta Pharmaceuticals, Inc. | 23-O-substituted 5-O-mycaminosyltylonide derivatives |
| WO2005118610A2 (en) | 2004-06-01 | 2005-12-15 | Rib-X Pharmaceuticals, Inc. | Macrocyclic compounds and methods of making and using the same |
| US7247617B2 (en) | 2004-07-13 | 2007-07-24 | Kosan Biosciences Incorporated | Sixteen-member macrolide antiinfective agents |
| US7282487B2 (en) * | 2004-10-28 | 2007-10-16 | Idexx Laboratories | Method for treating bacterial infections in horses or pigs with tilmicosin |
| DE102005061326A1 (de) | 2005-12-20 | 2007-06-21 | Basell Polyolefine Gmbh | Verfahren zur Herstellung von Metallocenen aus recycelten, substituierten Cyclopentadienylderivaten |
| EP2019112A1 (en) * | 2007-07-26 | 2009-01-28 | Intervet International BV | Macrolide solid-state forms |
| JP5323696B2 (ja) | 2006-07-28 | 2013-10-23 | インターベツト・インターナシヨナル・ベー・ベー | マクロライド合成方法 |
| CN101506220B (zh) * | 2006-07-28 | 2012-10-17 | 英特威国际有限公司 | 大环内酯合成方法 |
| WO2009064953A1 (en) | 2007-11-15 | 2009-05-22 | Enanta Pharmaceuticals, Inc. | Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases |
| US20110071096A1 (en) * | 2009-09-23 | 2011-03-24 | Idexx Laboratories, Inc. | Macrolides Having Antibiotic Activity |
| BR112014012585B1 (pt) | 2011-11-25 | 2021-05-25 | Bayer Intellectual Property Gmbh | composto compreendendo derivados de tilosina, método de preparo do mesmo e composição farmacêutica ou veterinária |
-
2014
- 2014-05-23 NO NO14725726A patent/NO2999707T3/no unknown
- 2014-05-23 CA CA2913098A patent/CA2913098C/en active Active
- 2014-05-23 EP EP14725726.5A patent/EP2999707B1/en active Active
- 2014-05-23 SI SI201430717T patent/SI2999707T1/en unknown
- 2014-05-23 DK DK14725726.5T patent/DK2999707T3/en active
- 2014-05-23 UA UAA201512523A patent/UA117751C2/uk unknown
- 2014-05-23 PE PE2015002434A patent/PE20160207A1/es unknown
- 2014-05-23 AU AU2014270353A patent/AU2014270353B2/en active Active
- 2014-05-23 TR TR2018/09189T patent/TR201809189T4/tr unknown
- 2014-05-23 PL PL14725726T patent/PL2999707T3/pl unknown
- 2014-05-23 BR BR112015029260A patent/BR112015029260A2/pt not_active Application Discontinuation
- 2014-05-23 ES ES14725726.5T patent/ES2669615T3/es active Active
- 2014-05-23 RU RU2015155032A patent/RU2714482C2/ru active
- 2014-05-23 MX MX2015016118A patent/MX361808B/es active IP Right Grant
- 2014-05-23 HU HUE14725726A patent/HUE037868T2/hu unknown
- 2014-05-23 CN CN201480041371.2A patent/CN105408340B/zh active Active
- 2014-05-23 WO PCT/EP2014/060665 patent/WO2014187957A1/en active Application Filing
- 2014-05-23 US US14/891,762 patent/US9771389B2/en active Active
- 2014-05-23 JP JP2016514434A patent/JP6494600B2/ja active Active
- 2014-05-23 PT PT147257265T patent/PT2999707T/pt unknown
- 2014-05-23 KR KR1020157035927A patent/KR102307218B1/ko active IP Right Grant
- 2014-05-23 MY MYPI2015704210A patent/MY184630A/en unknown
-
2015
- 2015-11-11 IL IL242543A patent/IL242543B/en active IP Right Grant
- 2015-11-23 CL CL2015003433A patent/CL2015003433A1/es unknown
-
2016
- 2016-04-21 HK HK16104565.9A patent/HK1216753A1/zh unknown
-
2018
- 2018-06-05 HR HRP20180877TT patent/HRP20180877T1/hr unknown